9 results
Real-world savings in medication-related costs up to 5 years with the use of the second-generation trabecular implant (iStent inject®) in mild open-angle glaucoma
260
Real-world evidence of the costs avoided over one year with the use of selective laser trabeculoplasty as a substitute therapy for eye drops
418
A Brazilian cost-utility analysis of trabecular micro-bypass with iStent inject® for the treatment of open-angle glaucoma
1,036
Estimating the cost of training an ophthalmologist in Brazil
2,595
Preventing glaucoma progression using the trabecular micro-bypass implant iStent inject®. A cost-effectiveness analysis
811
Financial impact on glaucoma surgical treatment
291
Cost analysis for ophthalmic clinics services
456
Phacoemulsification versus extracapsular extraction on public health care system: cost analysis to the hospital, to the government and to the society
200
1 2